US 11643446
Progranulin variants
granted A61KA61K38/00A61P
Quick answer
US patent 11643446 (Progranulin variants) held by DENALI THERAPEUTICS INC. expires Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- DENALI THERAPEUTICS INC.
- Grant date
- Tue May 09 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 04 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 50
- CPC classes
- A61K, A61K38/00, A61P, A61P25/28